questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Interleukines
Interleukine-9
Interleukine-9 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Attention Deficit Disorder with Hyperactivity
Diagnostic
5
Tests de laboratoire
Interleukine-9
Interleukine-9
Inflammation
Symptômes
5
Asthme
Réactions allergiques
Interleukine-9
Hyperréactivité bronchique
Troubles gastro-intestinaux
Interleukine-9
Démangeaisons
Difficultés respiratoires
Prévention
5
Prévention des maladies
Allergènes
Éducation des patients
Allergies
Alimentation
Inflammation
Contrôle environnemental
Allergènes
Traitements
5
Antihistaminiques
Interleukine-9
Anticorps monoclonaux
Asthme
Corticostéroïdes
Interleukine-9
Bronchodilatateurs
Asthme
Immunothérapie
Interleukine-9
Complications
5
Exacerbations d'asthme
Réactions allergiques
Maladies auto-immunes
Interleukine-9
Surinfections
Interleukine-9
Complications pulmonaires
Fibrose
Troubles cardiovasculaires
Interleukine-9
Facteurs de risque
5
Antécédents familiaux
Asthme
Pollution de l'air
Interleukine-9
Infections respiratoires
Interleukine-9
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Interleukine-9 : Questions médicales les plus fréquentes",
"headline": "Interleukine-9 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Interleukine-9 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Interleukine-9"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Interleukines",
"url": "https://questionsmedicales.fr/mesh/D007378",
"about": {
"@type": "MedicalCondition",
"name": "Interleukines",
"code": {
"@type": "MedicalCode",
"code": "D007378",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.465"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Interleukine-9",
"alternateName": "Interleukin-9",
"code": {
"@type": "MedicalCode",
"code": "D016906",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sushmita Chakraborty",
"url": "https://questionsmedicales.fr/author/Sushmita%20Chakraborty",
"affiliation": {
"@type": "Organization",
"name": "Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India."
}
},
{
"@type": "Person",
"name": "Dipendra Kumar Mitra",
"url": "https://questionsmedicales.fr/author/Dipendra%20Kumar%20Mitra",
"affiliation": {
"@type": "Organization",
"name": "Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India."
}
},
{
"@type": "Person",
"name": "Mattia Matasci",
"url": "https://questionsmedicales.fr/author/Mattia%20Matasci",
"affiliation": {
"@type": "Organization",
"name": "Philochem AG, CH-8112 Otelfingen, Switzerland."
}
},
{
"@type": "Person",
"name": "Dario Neri",
"url": "https://questionsmedicales.fr/author/Dario%20Neri",
"affiliation": {
"@type": "Organization",
"name": "Philochem AG, CH-8112 Otelfingen, Switzerland."
}
},
{
"@type": "Person",
"name": "Katharina F Kubatzky",
"url": "https://questionsmedicales.fr/author/Katharina%20F%20Kubatzky",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University, Heidelberg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Attention-Deficit / Hyperactivity Disorder in Athletes.",
"datePublished": "2023-07-24",
"url": "https://questionsmedicales.fr/article/37949508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.csm.2023.06.013"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comorbid attention-deficit hyperactivity disorder and bipolar disorder.",
"datePublished": "2023-02-01",
"url": "https://questionsmedicales.fr/article/36726332",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00048674231154203"
}
},
{
"@type": "ScholarlyArticle",
"name": "Attention Deficit Hyperactivity Disorder in Adults With Migraine.",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37752867",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10870547231199256"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleep in Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder.",
"datePublished": "2023-08-29",
"url": "https://questionsmedicales.fr/article/37919035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.spen.2023.101076"
}
},
{
"@type": "ScholarlyArticle",
"name": "Transcriptomic risk scores for attention deficit/hyperactivity disorder.",
"datePublished": "2023-08-03",
"url": "https://questionsmedicales.fr/article/37537283",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41380-023-02200-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Interleukines",
"item": "https://questionsmedicales.fr/mesh/D007378"
},
{
"@type": "ListItem",
"position": 6,
"name": "Interleukine-9",
"item": "https://questionsmedicales.fr/mesh/D016906"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Interleukine-9 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Interleukine-9",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Interleukine-9",
"description": "Comment mesurer l'interleukine-9 ?\nQuels tests sont utilisés pour le diagnostic ?\nL'IL-9 est-elle liée à des maladies spécifiques ?\nQuels biomarqueurs sont associés à l'IL-9 ?\nL'IL-9 peut-elle être un indicateur de gravité ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Interleukine-9",
"description": "Quels symptômes sont liés à l'IL-9 ?\nL'IL-9 provoque-t-elle des symptômes respiratoires ?\nY a-t-il des symptômes cutanés associés ?\nL'IL-9 est-elle liée à des symptômes gastro-intestinaux ?\nQuels signes cliniques sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Interleukine-9",
"description": "Comment prévenir les maladies liées à l'IL-9 ?\nY a-t-il des vaccins pour l'IL-9 ?\nL'éducation des patients est-elle importante ?\nLes changements alimentaires peuvent-ils aider ?\nLe contrôle de l'environnement est-il crucial ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Interleukine-9",
"description": "Comment traiter les niveaux élevés d'IL-9 ?\nY a-t-il des thérapies ciblées pour l'IL-9 ?\nLes corticostéroïdes affectent-ils l'IL-9 ?\nQuels médicaments sont utilisés pour l'asthme lié à l'IL-9 ?\nL'immunothérapie aide-t-elle avec l'IL-9 ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Interleukine-9",
"description": "Quelles complications peuvent survenir avec l'IL-9 ?\nL'IL-9 peut-elle aggraver d'autres maladies ?\nY a-t-il des risques de surinfection ?\nDes complications pulmonaires sont-elles possibles ?\nL'IL-9 est-elle liée à des troubles cardiovasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Interleukine-9",
"description": "Quels sont les facteurs de risque pour l'IL-9 ?\nL'exposition à la pollution augmente-t-elle le risque ?\nLe tabagisme influence-t-il l'IL-9 ?\nLes infections respiratoires sont-elles un facteur ?\nLe stress a-t-il un impact sur l'IL-9 ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer l'interleukine-9 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-9 peut être mesurée par des tests ELISA dans le sérum ou les fluides biologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de cytokines sont utilisés pour évaluer l'IL-9."
}
},
{
"@type": "Question",
"name": "L'IL-9 est-elle liée à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 est associée à des maladies comme l'asthme et certaines allergies."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont associés à l'IL-9 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-9 est souvent mesurée avec d'autres cytokines comme l'IL-4 et l'IL-5."
}
},
{
"@type": "Question",
"name": "L'IL-9 peut-elle être un indicateur de gravité ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés d'IL-9 peuvent indiquer une inflammation sévère."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'IL-9 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des réactions allergiques, de l'asthme et des inflammations."
}
},
{
"@type": "Question",
"name": "L'IL-9 provoque-t-elle des symptômes respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 est impliquée dans l'hyperréactivité bronchique et l'asthme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent survenir dans des conditions allergiques liées à l'IL-9."
}
},
{
"@type": "Question",
"name": "L'IL-9 est-elle liée à des symptômes gastro-intestinaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 peut être impliquée dans des troubles gastro-intestinaux allergiques."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont observés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des difficultés respiratoires, des éruptions cutanées et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées à l'IL-9 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les allergènes et adopter un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins pour l'IL-9 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques pour cibler l'IL-9."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les déclencheurs allergiques est essentiel pour la prévention."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires peuvent-ils aider ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut aider à réduire l'inflammation et les symptômes."
}
},
{
"@type": "Question",
"name": "Le contrôle de l'environnement est-il crucial ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, réduire l'exposition aux allergènes environnementaux est essentiel pour la prévention."
}
},
{
"@type": "Question",
"name": "Comment traiter les niveaux élevés d'IL-9 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements anti-inflammatoires et des antihistaminiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies ciblées pour l'IL-9 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticorps monoclonaux ciblant l'IL-9 sont en développement pour traiter l'asthme."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes affectent-ils l'IL-9 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire les niveaux d'IL-9 et l'inflammation associée."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour l'asthme lié à l'IL-9 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les bronchodilatateurs et les corticostéroïdes sont couramment prescrits."
}
},
{
"@type": "Question",
"name": "L'immunothérapie aide-t-elle avec l'IL-9 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'immunothérapie peut aider à moduler la réponse immunitaire liée à l'IL-9."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'IL-9 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des exacerbations d'asthme et des réactions allergiques sévères."
}
},
{
"@type": "Question",
"name": "L'IL-9 peut-elle aggraver d'autres maladies ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 peut exacerber des maladies auto-immunes et inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de surinfection ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients avec des niveaux élevés d'IL-9 peuvent être à risque de surinfections."
}
},
{
"@type": "Question",
"name": "Des complications pulmonaires sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 peut contribuer à des complications pulmonaires comme la fibrose."
}
},
{
"@type": "Question",
"name": "L'IL-9 est-elle liée à des troubles cardiovasculaires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre l'IL-9 et des troubles cardiovasculaires, mais c'est encore à étudier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'IL-9 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux d'allergies et d'asthme augmentent le risque d'IL-9 élevée."
}
},
{
"@type": "Question",
"name": "L'exposition à la pollution augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pollution de l'air est un facteur de risque connu pour les maladies liées à l'IL-9."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'IL-9 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter les niveaux d'IL-9 et aggraver les symptômes respiratoires."
}
},
{
"@type": "Question",
"name": "Les infections respiratoires sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections respiratoires peuvent déclencher une réponse immunitaire impliquant l'IL-9."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur l'IL-9 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et augmenter les niveaux d'IL-9."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
5 publications dans cette catégorie
Affiliations :
Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
4 publications dans cette catégorie
Affiliations :
Philochem AG, CH-8112 Otelfingen, Switzerland.
Publications dans "Interleukine-9" :
4 publications dans cette catégorie
Affiliations :
Philochem AG, CH-8112 Otelfingen, Switzerland.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University, Heidelberg, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine I, Univerisity Hospital Jena, 07747 Jena, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine I, Univerisity Hospital Jena, 07747 Jena, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine I, Univerisity Hospital Jena, 07747 Jena, Germany.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Microbiology, Immunology and Parasitology Department, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.
International Corporation Laboratory of Agriculture and Agricultural Products Safety, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Brown Center for Immunotherapy, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Interleukine-9" :
ADHD is common among the general population and may be slightly more common among athletes. Diagnosis requires six or more DSM-5-TR symptoms to have been present prior to age 12 and to have an effect ...
The rate of comorbid attention-deficit hyperactivity disorder and bipolar disorder far exceeds chance if the two are independent conditions. Explanations for such a high comorbid prevalence and manage...
Several studies have shown increased occurrence of migraine in ADHD patients. However, there is less evidence on whether migraine patients also have a higher ADHD frequency. The aim of this paper is d...
An observational cohort study has been conducted. Patients with episodic migraine were included. The ADHD Rating scale, the Adult ADHD Self-Report Scale, and the scale of impulsiveness of Plutchik wer...
The mean value of inattention, hyperactivity and impulsivity scores on the ADHD scale was 5 ± 3.8 in cases and 2.7 ± 2.2 in controls (...
Adults with migraine have a higher prevalence of ADHD symptoms. This should be considered when assessing these patients....
SLEEP IN AUTISM SPECTRUM DISORDER AND ATTENTION DEFICIT HYPERACTIVITY DISORDER: Kanwaljit Singh, Andrew W. Zimmerman Seminars in Pediatric Neurology Volume 22, Issue 2, June 2015, Pages 113-125 Sleep ...
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association s...
Evidence that adult attention-deficit/hyperactivity disorder (ADHD) is associated with an increased risk of dementia is scarce and inconsistent, and potential sources of bias are untested....
To examine the association between adult ADHD and the risk of dementia....
This prospective national cohort study consisted of 109 218 members of a nonprofit Israeli health maintenance organization born between 1933 and 1952 who entered the cohort on January 1, 2003, without...
Adult ADHD was a time-varying covariate, classified as present from the age of the first diagnosis (using the International Classification of Diseases, Ninth Revision, and the International Statistica...
Cox regression models were fitted to quantify the association between adult ADHD and the risk of incident dementia with hazard ratios (HRs) and their 95% CIs unadjusted and in the primary analysis, us...
At the beginning of the follow-up, the sample of 109 218 participants had a mean (SD) age of 57.7 (5.5) years, 56 474 participants (51.7%) were female, and 52 744 (48.3%) were male. During follow-up, ...
In this cohort study of individuals born between 1933 and 1952 and followed up in old age, adult ADHD was associated with an increased risk of dementia. Policy makers, caregivers, patients, and clinic...
To evaluate rates of Attention-Deficit/Hyperactivity Disorder (AD/HD) diagnosis among pediatric patients with normal hearing (NH) and hearing loss (HL) with and without comorbidities....
Retrospective cohort study of NH and HL patients following chart review of all pediatric patients with a history of tympanostomy tube placement treated at the Cleveland Clinic Foundation between 2019 ...
Patient demographic information, hearing status (type of HL, laterality, severity), and comorbidities including prematurity, genetic syndromes, disorders with neurological impairment, and autism spect...
Of the 919 screened patients between 2019 and 2022, there were 778 NH patients and 141 HL patients (80 bilateral, 61 unilateral). HL ranged from mild (n = 110) to moderate (n = 21) to severe/profound ...
The rate of AD/HD among children with HL (12.1%) is higher than the rate of AD/HD in NH children (3.6%), consistent with previous findings. After excluding patients with comorbidities and adjusting fo...
Attention-Deficit/Hyperactivity Disorder (ADHD), a prevalent childhood neurodevelopmental disorder with complex etiology involving genetic and environmental factors, causes impairments across various ...
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects individuals from all life stages, genders, and races/ethnicities. Accurate assessment of ADHD across diffe...
Childhood attention-deficit /hyperactivity disorder (ADHD) is known to be associated with adult Borderline Personality Disorder (BPD). We investigated if any of the subdimensions of childhood ADHD, th...
In a nation-wide cohort (N = 13,330), we utilized parent reported symptoms of childhood ADHD and clinically ascertained adult BPD diagnoses. The summed total scores of ADHD symptoms and its three subd...
ADHD symptom severity was positively associated with BPD with a hazard ratio (HR) of 1.47 (95% confidence interval [CI]: 1.22-1.79) per standard deviation increase in total ADHD symptoms. Impulsivity ...
Childhood ADHD symptoms were associated with subsequent development of BPD diagnosis and appeared to be driven primarily by impulsivity. Our findings are important for understanding the association be...